mantle cell lymphoma

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

mantle cell lymphoma

Aug 25, 2024, 17:04 | Blog

Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka

Rahul Gosain shared on LinkedIn: “Hematology: with Pallawi Torka we discuss the current SoC/landscape for…

Aug 14, 2024, 14:08 | Insight

Michael Wang: Phenotype- and target-driven discovery are necessary for finding cures

Michael Wang shared on X a recent paper by Zhenyi Wang et al. titled "Innovating…

Jul 28, 2024, 14:02 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Patrick Hwu

We are excited to introduce Dr. Patrick Hwu, a leading expert in cancer immunotherapy, as…

Jul 21, 2024, 12:19 | Blog

Oncoinfluencers to Follow on Social Media: Dr. Michael Wang

At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…

Jul 13, 2024, 21:06 | Insight

Michael Wang: CDK9 is a promising target in MCL

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…

Jul 1, 2024, 02:17 | Opinion

Michael Wang: Excellent review of the actions and complex regulation of p53

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…

Jun 29, 2024, 16:57 | Insight

MD Anderson Research Highlights: EHA 2024 Special Edition

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…

Jun 20, 2024, 10:10 | Insight

Date of improved response rates in mantle cell lymphoma patients

MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…

Jun 17, 2024, 17:03 | Blog

Michael Wang: I presented the data from ECHO trial

Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…

Apr 15, 2024, 16:12 | Insight

Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates

Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…

Mar 31, 2024, 23:07 | Blog

Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma

Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…

Jan 3, 2024, 18:41 | Insight

Julie Vose: The long awaited publication from the NAMCL Project

Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…

Dec 27, 2023, 13:13 | Insight

Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma

Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…

All: 13 Posts: 1 - 100